Eleven Biotherapeutics reported 180.64M in Current Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Amgen AMGN:US $ 18520M 865M
Bayer BAYN:GR 38.25B 5.67B
Bristol Myers Squibb BMY:US $ 30121M 3141M
Corcept Therapeutics CORT:US $ 388.22M 121.76M
Eleven Biotherapeutics EBIO:US 180.64M 24.97M
Eli Lilly And LLY:US $ 16964.7M 1487.7M
Intrexon XON:US $ 154.94M 1.69M
Merk MRK:US $ 31184M 918M
Pfizer PFE:US $ 54420M 5273M
Rigel Pharmaceuticals RIGL:US $ 138.94M 15.53M
Ziopharm Oncology ZIOP:US $ 69.77M 9.06M